Alberto Auricchio, MD is Associate Professor of Medical Genetics at the “Federico II” University in Naples and Full Investigator, Director of Molecular and Therapy Program and AAV Vector Core Supervisor at the Telethon Institute of Genetics and Medicine in Naples. Prof Auricchio’s research is focused on gene therapy of retinal and metabolic diseases using adeno-associated viral vectors. Prof Auricchio is co-author of more than 120 peer-reviewed publications on international scientific journals and inventor on several international patents on the use of viral vectors for gene therapy.
Prof Auricchio is a member of the Editorial boards of Human Gene Therapy and Molecular Therapy. He received the 2006 Outstanding New Investigator Award of the American Society of Gene Therapy, and has been nominated in 2007 “Cavaliere of the Italian Republic” by the President of the Italian Republic. In July 2011 Prof Auricchio has been selected as recipient of a European Research Council Starting Grant. Finally, Prof Auricchio is coordinator of the five years EU funded project MeuSIX – “clinical trial of gene therapy for MPS VI – a severe lysosomal storage disorder” and is currently involved as senior scientist in a long-term strategic collaboration with Shire Pharmaceuticals over five years to provide exclusive